Equifax (NYSE:EFX) Updates Q4 Earnings Guidance

Equifax (NYSE:EFX) issued an update on its fourth quarter earnings guidance on Wednesday morning. The company provided earnings per share guidance of $2.08-2.18 for the period, compared to the consensus earnings per share estimate of $2.20. The company issued revenue guidance of $1.438-1.458 billion, compared to the consensus revenue estimate of $1.47 billion. Equifax also updated its FY 2024 guidance to 7.250-7.350 EPS.

Wall Street Analyst Weigh In

A number of research analysts have commented on the company. UBS Group assumed coverage on Equifax in a research note on Tuesday, October 1st. They set a “buy” rating and a $360.00 price objective on the stock. Robert W. Baird increased their price objective on shares of Equifax from $260.00 to $290.00 and gave the company an “outperform” rating in a research report on Friday, July 19th. The Goldman Sachs Group upped their target price on shares of Equifax from $277.00 to $307.00 and gave the company a “neutral” rating in a research note on Tuesday, August 20th. Stifel Nicolaus boosted their price objective on shares of Equifax from $265.00 to $305.00 and gave the stock a “buy” rating in a report on Friday, July 19th. Finally, Bank of America raised their target price on Equifax from $255.00 to $286.00 and gave the company a “buy” rating in a research note on Thursday, July 18th. Four investment analysts have rated the stock with a hold rating and sixteen have issued a buy rating to the company’s stock. Based on data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and a consensus price target of $307.74.

Equifax Stock Down 0.1 %

NYSE:EFX opened at $289.95 on Thursday. The company has a current ratio of 0.79, a quick ratio of 0.79 and a debt-to-equity ratio of 1.01. The stock has a 50 day moving average of $294.89 and a 200-day moving average of $262.68. The firm has a market capitalization of $35.84 billion, a PE ratio of 64.58, a price-to-earnings-growth ratio of 2.00 and a beta of 1.58. Equifax has a 52 week low of $159.95 and a 52 week high of $309.63.

Equifax (NYSE:EFX) last posted its earnings results on Wednesday, July 17th. The credit services provider reported $1.82 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.73 by $0.09. The company had revenue of $1.43 billion for the quarter, compared to analysts’ expectations of $1.42 billion. Equifax had a return on equity of 18.88% and a net margin of 10.67%. The firm’s quarterly revenue was up 8.6% compared to the same quarter last year. During the same period last year, the business posted $1.71 earnings per share. Analysts predict that Equifax will post 7.36 EPS for the current year.

Equifax Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Friday, September 13th. Investors of record on Tuesday, September 3rd were given a $0.39 dividend. This represents a $1.56 annualized dividend and a yield of 0.54%. The ex-dividend date of this dividend was Tuesday, September 3rd. Equifax’s dividend payout ratio is currently 34.74%.

Insiders Place Their Bets

In related news, EVP Carla Chaney sold 3,000 shares of Equifax stock in a transaction dated Wednesday, August 7th. The shares were sold at an average price of $281.85, for a total transaction of $845,550.00. Following the sale, the executive vice president now directly owns 10,875 shares in the company, valued at $3,065,118.75. The trade was a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. 1.57% of the stock is currently owned by insiders.

Equifax Company Profile

Equifax Inc operates as a data, analytics, and technology company. The company operates through three segments: Workforce Solutions, U.S. Information Solutions (USIS), and International. The Workforce Solutions segment offers services that enables customers to verify income, employment, educational history, criminal justice data, healthcare professional licensure, and sanctions of people in the United States; and employer customers with services that assist them in complying with and automating payroll-related and human resource management processes throughout the entire cycle of the employment relationship.